Abstract:
PURPOSE: A method for producing alkyl cis-4-amino-3- methoxy-1-piperidine carboxylate hydrochloride is provided, thereby the titled compound having high purity can be easily produced because the further purification steps are not required and the production is performed under the mild conditions. CONSTITUTION: The method for producing alkyl cis-4-amino-3- methoxy-1-piperidine carboxylate hydrochloride represented by formula (I) comprises the steps of: reacting alkyl trans-4-bromo-3- hydroxypiperidine-1-carboxylate of formula (III) with benzoyl isocyanate in organic solvents to produce alkyl trans-4-bromo-3- benzoylaminocarbonyloxy-1-piperidine carboxylate of formula (IV); adding base such as kalium tert-butoxide into the compound of formula (IV) to produce alkyl cis-1-benzoyl-2-oxo- hexahydro-oxazolo(5,4,c) pyridine-5-carboxylate of formula (V); reacting the compound of formula (V) with lithium hydroxide·H2O to produce alkyl cis-2-oxo-hexahydro-oxazolo(5,4-c) pyridine-5-carboxylate of formula (VI); reacting the compound of formula (VI) with triethylamine, di-tert-butoxy dicarbonate, and dimethylaminopyridine to produce cis-1-tert- butoxycarbonyl-5- ethoxycarbonyl-2-oxo- hexahydro- oxazolo(5,4-c) pyridine of formula (VII); reacting the compound of formula (VII) with cesium carbonate to produce alkyl cis-4-tert- butoxycarbonyl amino-3-hydroxy-1-piperidine carboxylate of formula (VIII); adding sodium hydroxide, dimethyl sulfate, and benzyltriethyl ammonium chloride into the compound of formula (VIII) to produce alkyl cis-4-tert-butoxycarbonylamino- 3-methoxy-1-piperidine carboxylate of formula (IX); and adding hydrogen chloride dissolved organic solvent into the compound of formula (IX) to produce alkyl cis-4-amino-3- methoxy-1-piperidine carboxylate hydrochloride of formula (I).
Abstract:
PURPOSE: A process for producing squalamine is provided, thereby the squalamine can be cheaply and simply produced due to the use of cheap 3-keto-bisnocholenol as an initial compound. CONSTITUTION: The process for producing squalamine of formula(1) comprises the steps of: protecting a 3-keto group of 3-keto-bisnocholenol of formula(2) with an ethylenekital group and converting primary alcohol at C22 into an aldehyde group to produce 3-ethylenekital-23,24-bisnochola-5-en-22-al of formula(3); aldol condensing the compound of formula(3) to produce inone compound, hydrogenating the inone compound in the presence of platinum catalyst to produce 3-ethylenekital-cholest-5-en-24-on of formula(4); allyl oxidizing the compound of formula(4) to produce 3-ethylenekital-cholest-5-en-7,24-dion; selectively reducing double bond of the compound of formula(5) at C5 to produce 5alpha-cholestan and stereo selectively reducing a kito group at C7 and treating it with hydrochloric acid to produce 3-kito-5-alpha-cholestan-7,24-diol of formula(6); protecting hydroxy at C24 of the compound of formula(6) with t-butyldimethylsilyl, and converting kito at C3 to 3alpha-amino to produce 3alpha-amino-7,24-dihydroxycholest-5-en of formula(7); reacting the compound of formula(7) with polyamine aldehyde of formula(8) to produce a compound of formula(9); and treating the compound of formula(9) with acid to remove silly and a carbamate protecting group and to insert sulfone into the C24 site.
Abstract:
본 발명은 스테로이드계 의약품 중간체의 제조방법에 관한 것으로서, 더욱 상세하게는 다음 화학식 2로 표시되는 키노데옥시콜릭 산을 출발물질로 사용하여 스테로이드계 의약품의 중간체로 유용한 다음 화학식 1로 표시되는 3-키토-5α-콜레스탄-24-올을 제조하는 방법에 관한 것이다.
Abstract:
본 발명은 스테로이드계 의약품 중간체의 제조방법에 관한 것으로서, 더욱 상세하게는 다음 화학식 2로 표시되는 키노데옥시콜릭 산을 출발물질로 사용하여 스테로이드계 의약품의 중간체로 유용한 다음 화학식 1로 표시되는 3-키토-5α-콜레스탄-24-올을 제조하는 방법에 관한 것이다.